Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41

Molecular Pharmacology

Volumn 58, Issue 5, 2000, Pages 982-992

  O'Keefe, Barry R ^a   Shenoy, Shilpa R ^a   Xie, Dong ^b   Zhang, Wentao ^c   Muschik, Jeffrey M ^a   Currens, Michael J ^a   Chaiken, Irwin ^c   Boyd, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYANOVIRIN N; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BIOSENSOR; CALORIMETRY; CIRCULAR DICHROISM; DRUG PROTEIN BINDING; FLUORESCENCE POLARIZATION; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; STOICHIOMETRY; VIRUS ENVELOPE;

EID: 0033789322     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.5.982     Document Type: Article

References (32)

1. Evaluation of secondary structure of proteins from UV circular dichroism using an unsupervised learning neural network
2. Solution structure of cyanovirin-N, a potent HIV-inactivating protein
3. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development
4. HIV entry and its inhibition
5. Multiple antiviral activities of cyanovirin-N: Blocking of gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses
6. On the meaning of affinity: Cluster glycoside effects and Concanavalin A
7. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled coil pocket
8. Cyanovirin-N binds to gp120 to interfere with CD4-dependent HIV-1 Virion binding, infectivity, and fusion but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120
9. The role of human immunodeficiency virus type 1 envelope giycoproteins in virus infection
10. Carbohydrates of human immunodeficiency virus: Structures of oligosaccharides linked to the envelope glycoprotein 120
11. Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum
12. A semi-automated multiparameter assay for anti-HIV drug screening
13. Inhibition of HIV type I infectivity by constrained α-helical peptides: Implications for the viral fusion mechanism
14. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralising human antibody
15. Sensing the heat: The application of isothermal titration calorimetry to the thermodynamic studies of bimolecular interactions
16. HIV-1 membrane fusion mechanism: Structural studies of the interactions between biologically active peptides from gp41
17. The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding
18. Siamenol, a new carbazole alkaloid from Murraya siamensis
19. Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus I from lymphoblastoid ceil line H9
20. Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium
21. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein
22. Simple, rapid, quantitative syncytium forming microassay for the detection of human immunodeficiency virus neutralizing antibody
23. Efficacy of fusion peptide homologs in blocking cell lysis and HIV-induced fusion
24. The effect of inhibitor binding on the structural stability and cooperativity of the HIV-1 protease
25. The ectedomain of HIV-1 env subunit gp41 forms a soluble a-helical, red-like oligomer in the absence of gp120 and the N-terminal fusion peptide
26. A synthetic peptide inhibiter of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
27. Peptides corresponding to a predictive alpha helical domain of HIV-1 gp41 are potent inhibiters of virus infection
28. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
29. Crystal structure of a potent HIV-inactivating protein cyanovirin-N shows unexpected domain swapping
30. Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system